Evofem Biosciences, Inc.
Please note: The information displayed on this page might be outdated.
Evofem Biosciences, Inc.:
Evofem Biosciences (EVFM) is developing Amphora®, a Multipurpose Vaginal pH Regulator (MVP-R) and non-hormonal, on-demand, woman-controlled vaginal gel for birth control and the prevention of urogenital acquisition of certain STIs. In December 2018, the Company reported positive top-line data from its confirmatory Phase 3 study in ~1400 women in the US; submitted NDA for Amphora in Nov 2019, PDUFA of 5.25.20 with a potential US launch in 2020. Dec 2019 announced positive topline results of Ph 2b trial of Amphora for the prevention of chlamydia and gonorrhea.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Pacific
Clinical Stage
Phase III
Disease Space
Men's Health, Women's Health
Industry
Biotechnology
Listing
Public, USA
Market Cap
100MM - 500MM
Website:
Address:
12400 High Bluff Drive
Suite 600
San Diego, CA 92130
United States
Suite 600
San Diego, CA 92130
United States
More info:
My account:
Company Participants at Solebury Trout Management Access SF 2020
- Amy Raskopf, Investor Relations
- Cara Miller, VP, Corporate Communications & Public Relations
- Jay File, Chief Financial Officer
- Kelly Culwell, Chief Medical Officer
- Russ Barrans, Chief Commercial Officer
- Saundra Pelletier, CEO
- Thomas Lynch, Chairman of the Board
Top 10 Holders of Evofem Biosciences Inc Warrant 2018-22.05.25 on Evofem Bioscienc
| Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
|---|---|---|---|---|---|
| Bessemer Investment Management LLC | 0.00 | 0 | 0.00 | 13F | 9/30/20 |
| Taylor Wealth Management Partners LLC | 0.00 | 0 | 0.00 | 13F | 9/30/20 |
Top 10 Holders of Evofem Biosciences, Inc.
| Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
|---|---|---|---|---|---|
| Invesco Asset Management Ltd. | 27.07 | 12,670,052 | 34.46 | 13F | 9/30/20 |
| The Vanguard Group, Inc. | 7.80 | 3,653,322 | 9.94 | Funds | 12/31/20 |
| Vanguard Group, Inc. (Subfiler) | 7.08 | 3,313,127 | 9.01 | 13F | 9/30/20 |
| BlackRock Fund Advisors | 5.19 | 2,430,313 | 6.61 | 13F | 9/30/20 |
| Heartland Advisors, Inc. | 4.96 | 2,319,650 | 6.31 | 13F | 9/30/20 |
| BlackRock Institutional Trust Co. NA | 4.50 | 2,105,592 | 5.73 | 13F | 9/30/20 |
| Jupiter Asset Management Ltd. | 2.64 | 1,237,613 | 3.37 | 13F | 9/30/20 |
| Schroder Investment Management International Ltd. | 2.36 | 1,105,406 | 3.01 | 13F | 9/30/20 |
| Geode Capital Management LLC | 2.27 | 1,060,876 | 2.89 | 13F | 9/30/20 |
| Hound Partners LLC | 2.21 | 1,033,327 | 2.81 | 13F | 9/30/20 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.